H.C. Wainwright Reiterates Buy Rating on Vivani Medical, Inc. (VANI)

July 10, 2026 6:51 AM

H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $3.50 price target on Vivani Medical, Inc. (NASDAQ: VANI).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found